Showing results (31-40 of 289) with videos related to

Sort By:
Pageof 29
Thyroid : Official Journal of the American Thyroid Association|March 8, 2023
Large (>4 cm) Intrathyroidal Encapsulated Well-Differentiated Follicular Cell-Derived Carcinoma Without Vascular Invasion May Have Negligible Risk of Recurrence Even When Treated with Lobectomy AloneRonald Ghossein, Ian Ganly, R Michael Tuttle, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 12, 2018
Implementing Key Changes in the American Thyroid Association 2015 Thyroid Nodules/Differentiated Thyroid Cancer Guidelines Across Practice TypesChristine L Twining, Mark A Lupo, R Michael Tuttle
Cancer|April 4, 2017
Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinomaMona M Sabra, Eric J Sherman, R Michael Tuttle
The Lancet. Diabetes & Endocrinology|November 27, 2015
Management of advanced medullary thyroid cancerJulien Hadoux, Furio Pacini, R Michael Tuttle, et al.
Clinical Endocrinology|April 28, 2011
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancerF Vaisman, A Shaha, S Fish, et al.
The Lancet. Diabetes & Endocrinology|August 24, 2016
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?Sophie Leboulleux, R Michael Tuttle, Furio Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancerAzeez Farooki, Vivien Leung, Hernan Tala, et al.
CA: a Cancer Journal for Clinicians|November 2, 2017
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manualNancy D Perrier, James D Brierley, R Michael Tuttle
Otolaryngologic Clinics of North America|June 14, 2003
Postoperative management of differentiated thyroid cancerErik G Cohen, R Michael Tuttle, Dennis H Kraus
Thyroid : Official Journal of the American Thyroid Association|December 6, 2011
In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin responseFernanda Vaisman, Hernan Tala, Ravinder Grewal, et al.
Pageof 29